Patient-reported and actionable safety events in CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 7, 2014, Pages 1564-1573

  Ginsberg, Jennifer S ^a   Zhan, Min ^a   Diamantidis, Clarissa J ^a   Woods, Corinne ^b   Chen, Jingjing ^a   Fink, Jeffrey C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM;

ADVERSE OUTCOME; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CHRONIC KIDNEY DISEASE; DIZZINESS; DRUG SAFETY; FEMALE; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT SAFETY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SELF REPORT; ADVERSE DRUG REACTION; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DATA MINING; MIDDLE AGED;

CHRONIC KIDNEY DISEASE; DATA MINING; PATIENT SAFETY;

AGED; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SELF REPORT;

EID: 84907207087     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090921     Document Type: Article

References (39)

1. Leape L, Berwick D, Clancy C, Conway J, Gluck P, Guest J, Lawrence D, Morath J, O'Leary D, O'Neill P, Pinakiewicz D, Isaac T; Lucian Leape Institute at the National Patient Safety Foundation: Transforming healthcare: A safety imperative. Qual Saf Health Care 18: 424-428, 2009
2. Leape LL, Berwick DM: Five years after To Err Is Human: What have we learned? JAMA 293: 2384-2390, 2005
3. McCannon CJ, Hackbarth AD, Griffin FA: Miles to go: An introduction to the 5 million lives campaign. Jt Comm J Qual Patient Saf 33: 477-484, 2007
4. Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC: Chronic kidney disease adversely influences patient safety. J AmSoc Nephrol 19: 2414-2419, 2008
5. Chapin E, Zhan M, Hsu VD, Seliger SL, Walker LD, Fink JC: Adverse safety events in chronic kidney disease: The frequency of "multiple hits". Clin J Am Soc Nephrol 5: 95-101, 2010
6. Fink JC, ChertowGM:Medication errors in chronic kidney disease:One piece in the patient safety puzzle. Kidney Int 76: 1123-1125, 2009
7. Nitsch D, Nonyane BAS, Smeeth L, Bulpitt CJ, Roderick PJ, Fletcher A: CKD and hospitalization in the elderly: A community-based cohort study in the United Kingdom. Am J Kidney Dis 57: 664-672, 2011
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
9. Fink JC, Brown J, Hsu VD, Seliger SL, Walker L, Zhan M: CKD as an underrecognized threat to patient safety.AmJ KidneyDis 53: 681-688, 2009
10. Chen Q, Chen YP: Mining frequent patterns for AMP-activated protein kinase regulation on skeletal muscle. BMC Bioinformatics 7: 394, 2006
11. Morgan XC, Ni S, Miranker DP, Iyer VR: Predicting combinatorial binding of transcription factors to regulatory elements in the human genome by association rule mining. BMC Bioinformatics 8: 445, 2007
12. Creighton C, Hanash S: Mining gene expression databases for association rules. Bioinformatics 19: 79-86, 2003
13. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
14. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl JMed 355: 2071-2084, 2006
15. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, WolfsonM, Reddan D; CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl JMed 355: 2085-2098, 2006
16. Diamantidis CJ, Seliger SL, Zhan M, Walker L, Rattinger GB, Hsu VD, Fink JC: A varying patient safety profile between black and nonblack adults with decreased estimated GFR. AmJ KidneyDis 60: 47-53, 2012
17. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr, Wang X, Greene T, Appel LJ, Lewis J; AASK Study Group: Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 48: 739-751, 2006
18. MoenMF, ZhanM, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC: Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 4: 1121-1127, 2009
19. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169: 1156-1162, 2009
20. Perazella MA: Drug-induced hyperkalemia: old culprits and new offenders. Am J Med 109: 307-314, 2000
21. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543-551, 2004
22. Luyckx VA: Nephrotoxicity of alternative medicine practice. Adv Chronic Kidney Dis 19: 129-141, 2012
23. Luyckx VA, Naicker S: Acute kidney injury associated with the use of traditional medicines. Nat Clin Pract Nephrol 4: 664-671, 2008
24. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R; Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA) Investigators: Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 165: 790-795, 2005
25. Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, Matheny ME, Bates DW: Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int 76: 1192-1198, 2009
26. LalibertéMC, NormandeauM, Lord A, Lamarre D, Cantin I, Berbiche D, Corneille L, Prud'homme L, Lalonde L: Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency. Am J Kidney Dis 49: 245-256, 2007
27. Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF: Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol 8: 1070-1078, 2013
28. Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B, Saran R, Saran R: Serum potassium and outcomes in CKD: Insights fromthe RRI-CKD cohort study. Clin J AmSocNephrol 5: 762-769, 2010
29. Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA; African American Study of Hypertension and Kidney Disease Collaborative Research Group: Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med 169: 1587-1594, 2009
30. Wang X: Investigating the impact of Medicare Part D on the diabetes medications using Enterprise iner and survival analysis. SAS Global Forum 2010, Seattle, Washington. Available at: http://support.sas.com/resources/papers/proceedings10/TOC.html. Accessed November 26, 2013
31. Breault JL, Goodall CR, Fos PJ: Datamining a diabetic data warehouse. Artif Intell Med 26: 37-54, 2002
32. Tian H, Brimmer DJ, Lin JM, Tumpey AJ, Reeves WC: Web usage data as a means of evaluating public health messaging and outreach. J Med Internet Res 11: e52, 2009
33. Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 111: 155A, 2000
34. Jolliffe IT: A note on the use of principal components in regression. J R Stat Soc Ser C Appl Stat 31: 300-303, 1982
35. Brown SGA, Stone SF, Fatovich DM, Burrows SA, Holdgate A, Celenza A, Coulson A, Hartnett L, Nagree Y, Cotterell C, Isbister GK. Anaphylaxis: Clinical patterns, mediator release, and severity. J Allergy Clin Immunol. 2013 (ePub).
36. Chen YL, Chen J, Tung C: A datamining approach for retail knowledge discovery with consideration of the effect of shelf-space adjacency on sales. Decision Support Systems and Electronic Commerce an International Journal. 42: 1503, 2006
37. Xin Y, Ju S: Mining conditional hybrid-dimension association rules on the basis of multi-dimensional transaction database. Machine Learning and Cybernetics, 2003 International Conference 1: 216-221, 2003.
38. Alvarez SA: Chi-squared computation for association rules: Preliminary results. Computer Science Department, Boston College, Chestnut Hill, MA, Technical Report BC-CS-2003-01. 2003.
39. Cerrito PB: Introduction to Data Mining Using SAS Enterprise Miner; 2006, Cary, NC, SAS Institute Inc., 2006